Tag: drug competition
Novo Nordisk’s Surprise 2026 Outlook Signals Intensifying Obesity Drug Competition
Danish obesity drugmaker Novo Nordisk faced a sharp negative market reaction on Wednesday after delivering a much weaker-than-expected outlook for 2026. The company warned...




